國立虎尾科技大學 |

New anti-cancer drug development and evaluation

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	New anti-cancer drug development and evaluation/ edited by Yongchang Zhang, Nong Yang.
其他作者:	Zhang, Yongchang.
出版者:	Singapore :Springer Nature Singapore : : 2024.,
面頁冊數:	xxvii, 232 p. :ill., digital ; : 24 cm.;
Contained By:	Springer Nature eBook
標題:	Antineoplastic agents. -
電子資源:	https://doi.org/10.1007/978-981-97-7274-2
ISBN:	9789819772742

New anti-cancer drug development and evaluation
New anti-cancer drug development and evaluation[electronic resource] /edited by Yongchang Zhang, Nong Yang. - Singapore :Springer Nature Singapore :2024. - xxvii, 232 p. :ill., digital ;24 cm.

Chapter 1. Transformations and Challenges in Cancer Treatment -- Chapter 2. Drug(gable) Targets Discovery -- Chapter 3. Preclinical and Translational Study Design -- Chapter 4. Clinical Trials -- Chapter 5. Small Molecule Compounds -- Chapter 6. Antibodies -- Chapter 7. Cell Guided Drugs -- Chapter 8. Gene Guided Drugs -- Chapter 9. Biosimilar -- Chapter 10. New Insights on Success and Failed Drugs -- Chapter 11. The Road from Laboratory to Patient.

This book aims to help researchers to understand the current status of new drug development in China and major events experienced in the development of new drugs. It also helps clinicians and basic research scientists to grasp the types, indications, and adverse reactions of common new drugs; clarifies key events experienced during the launch of new drugs; and discusses future perspectives of clinical medicine development. This book is also beneficial to clinicians by helping them to better become physician scientists.

ISBN: 9789819772742

Standard No.: 10.1007/978-981-97-7274-2doiSubjects--Topical Terms:

581036
Antineoplastic agents.

LC Class. No.: RC271.C5

Dewey Class. No.: 615.798

New anti-cancer drug development and evaluation
LDR:01952nam a2200325 a 4500 001 1153974
003 DE-He213
005 20241209115243.0
006 m d
007 cr nn 008maaau
008 250619s2024 si s 0 eng d
020 $a 9789819772742 $q (electronic bk.)
020 $a 9789819772735 $q (paper)
024 7 $a 10.1007/978-981-97-7274-2 $2 doi
035 $a 978-981-97-7274-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC271.C5
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 615.798 $2 23
090 $a RC271.C5 $b N532 2024
245 0 0 $a New anti-cancer drug development and evaluation $h [electronic resource] / $c edited by Yongchang Zhang, Nong Yang.
260 $a Singapore : $c 2024. $b Springer Nature Singapore : $b Imprint: Springer,
300 $a xxvii, 232 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1. Transformations and Challenges in Cancer Treatment -- Chapter 2. Drug(gable) Targets Discovery -- Chapter 3. Preclinical and Translational Study Design -- Chapter 4. Clinical Trials -- Chapter 5. Small Molecule Compounds -- Chapter 6. Antibodies -- Chapter 7. Cell Guided Drugs -- Chapter 8. Gene Guided Drugs -- Chapter 9. Biosimilar -- Chapter 10. New Insights on Success and Failed Drugs -- Chapter 11. The Road from Laboratory to Patient.
520 $a This book aims to help researchers to understand the current status of new drug development in China and major events experienced in the development of new drugs. It also helps clinicians and basic research scientists to grasp the types, indications, and adverse reactions of common new drugs; clarifies key events experienced during the launch of new drugs; and discusses future perspectives of clinical medicine development. This book is also beneficial to clinicians by helping them to better become physician scientists.
650 0 $a Antineoplastic agents. $3 581036
650 0 $a Cancer $x Chemotherapy. $3 645264
650 0 $a Drug development. $3 581824
650 1 4 $a Pharmacology. $3 583819
650 2 4 $a Preclinical Research. $3 1402279
650 2 4 $a Clinical Research. $3 1366605
700 1 $a Zhang, Yongchang. $3 1481558
700 1 $a Yang, Nong. $3 1481559
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-97-7274-2
950 $a Medicine (SpringerNature-11650)